MetLife Investment Management’s Pulmonx LUNG Stock Holding History

MetLife Investment Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,244	Closed	-$150K	–	2889
2025 Q1	$150K	Hold	22,244	–	–	﹤0.01%	2345
2024 Q4	$151K	Hold	22,244	–	–	﹤0.01%	2438
2024 Q3	$184K	Hold	22,244	–	–	﹤0.01%	2328
2024 Q2	$141K	Buy	22,244 +2,017	+10%	+$15.5K	﹤0.01%	2442
2024 Q1	$188K	Hold	20,227	–	–	﹤0.01%	2237
2023 Q4	$258K	Hold	20,227	–	–	﹤0.01%	2090
2023 Q3	$209K	Hold	20,227	–	–	﹤0.01%	2180
2023 Q2	$265K	Hold	20,227	–	–	﹤0.01%	2097
2023 Q1	$226K	Hold	20,227	–	–	﹤0.01%	2141
2022 Q4	$171K	Hold	20,227	–	–	﹤0.01%	2351
2022 Q3	$337K	Buy	20,227 +2,164	+12%	+$39.8K	﹤0.01%	1919
2022 Q2	$266K	Buy	18,063 +2,272	+14%	+$46.8K	﹤0.01%	2109
2022 Q1	$392K	Buy	15,791 +5,828	+58%	+$151K	﹤0.01%	1934
2021 Q4	$320K	Hold	9,963	–	–	﹤0.01%	1774
2021 Q3	$358K	Hold	9,963	–	–	﹤0.01%	1720
2021 Q2	$440K	Buy	9,963 +4,632	+87%	+$202K	﹤0.01%	1644
2021 Q1	$244K	Hold	5,331	–	–	﹤0.01%	1944
2020 Q4	$368K	Buy	+5,331	New	+$261K	﹤0.01%	1635

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

MetLife Investment Management's LUNG Position: Q2 2025 in Review

MetLife Investment Management sold out of Pulmonx (LUNG) in Q2 2025, closing a stake of 22,244 shares — an estimated $150K sold.

MetLife Investment Management first reported a position in LUNG in Q4 2020 and held it in 18 quarters. The position peaked at $440K in Q2 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2025.

MetLife Investment Management reported no remaining Pulmonx position as of Q2 2025 after selling out during the quarter.
MetLife Investment Management sold 22,244 Pulmonx shares in Q2 2025, an estimated $150K.
MetLife Investment Management first reported a position in Pulmonx in Q4 2020 and held it in 18 quarters.
MetLife Investment Management's Pulmonx position peaked at $440K in Q2 2021.
113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2025.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.